ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Nearly 3,000 certified As Oncology Nurses

January 8, 1988

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

ASCO, NCCN Develop Quality Measures For Cancer Care

August 25, 2006

In Brief: Wynder To Receive Distinguished Achievement Award From ASPO; Brown Heads council Of Deans

February 24, 1984